Par Drugs & Chemicals Ltd

NSE : PAR24 Jan 2025

Pharmaceuticals

₹

+3.05 (+1.52%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Par Drugs & Chemicals Ltd

Par Drugs & Chemicals Ltd

Pharmaceuticals

NSE : PAR24 Jan 2025

₹

+3.05 (+1.52%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
09-Nov-2021	D	Par Drugs And Chemicals Limited has informed the Exchange about Dividend Updates	22-Nov-2021
01-Jun-2020	D	Par Drugs And Chemicals Limited has informed the Exchange that Board of Directors at its meeting held on Jun 01, 2020, recommended Final Dividend of 1.25 per equity share.	10-Jul-2020
11-Nov-2019	D	Par Drugs And Chemicals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 11, 2019 has declared an Interim dividend on equity share at the rate of 12.50% i.e. Rs. 1.25 per equity share of the face value of Rs. 10 each of Equity shareholders of the company.	22-Nov-2019
19-Apr-2021	B	Adjustment of Market Lot for security PARin SME PlatforM ar Drugs and Chemicals Limitedhas informed the Exchange that the Company has fixed Record Date as April 28 2021 for the purpose of issue of Bonus shares in the ratio of 1:1(OneEquity shares oF Rs.10/-each for every Onefully paid up Equity Share of Rs.10/-held by the shareholders) Symbol PAR Bonus issue ratio : 1:1 Ex-Date April 27, 2021 The adjusted market lot on account of bonus issue shall be 4000 The above changes shall be effective from April 27, 2021 Members are advised to load the updated security.gz/nnf_security.gz file in the trading application before trading on April 27, 2021. These files can be obtained from the directory common/NTNEAT on the Extranet server For and on behalf ofNational Stock Exchange of India Limited	28-Apr-2021	1:1
20-Jan-2025	BC	Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on February 12, 2025	12-Feb-2025
11-Jan-2025	BC	The Board considered and decided to call an Extra Ordinary General Meeting on Wednesday 12th February, 202$ through Video Conferencing ('VC') mode/ Other Audio Visual Means ('OAVM') in accordance wit	05-Feb-2025
08-Jan-2025	BC	Pursuant to Regulation 30 and all other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time ('Listing Regulations') re	15-Jan-2025
08-Jan-2025	BC	To consider other business matters Outcome of Board Meeting dated 11.01.2025 (As Per NSE Announcement Dated on: 11/01/2025)	11-Jan-2025
06-Dec-2024	BC	Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on December 31, 2024 Par Drugs And Chemicals Limited has informed the Exchang	31-Dec-2024

No Rights has been declared by PAR

Book Closure

Record Date	Split Date	Purpose
12-Feb-2025	-	Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on February 12, 2025
05-Feb-2025	-	The Board considered and decided to call an Extra Ordinary General Meeting on Wednesday 12th February, 202$ through Video Conferencing ('VC') mode/ Other Audio Visual Means ('OAVM') in accordance wit
15-Jan-2025	-	Pursuant to Regulation 30 and all other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time ('Listing Regulations') re
11-Jan-2025	-	To consider other business matters Outcome of Board Meeting dated 11.01.2025 (As Per NSE Announcement Dated on: 11/01/2025)
31-Dec-2024	-	Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on December 31, 2024 Par Drugs And Chemicals Limited has informed the Exchang

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Par Drugs & Chemicals Ltd ₹203.07(+3.05/1.52%)	203.07	+3.05	249.87	1.76	13.67	2.58
Lupin Ltd ₹2,134.25(-16.95/-0.79%)	2,134.25	-16.95	97,371.86	47.27	32.48	4.43
Ipca Laboratories Ltd ₹1,515.85(-67.70/-4.28%)	1,515.85	-67.70	38,457.75	38.00	55.11	5.71
J B Chemicals & Pharmaceuticals Ltd ₹1,779.95(-25.70/-1.42%)	1,779.95	-25.70	27,686.90	5.09	46.13	8.77
IOL Chemicals & Pharmaceuticals Ltd ₹379.05(-7.65/-1.98%)	379.05	-7.65	2,225.23	-13.06	22.21	1.34
Sanofi India Ltd ₹5,334.60(-25.30/-0.47%)	5,334.60	-25.30	12,285.58	-36.70	29.13	17.93

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	22.24	16.21	21.16	7.38	0.03
Net Cash from Operating Activities	20.25	13.38	7.62	12.09	7.69
Net Cash Used In Investing Activities	-5.84	-7.34	-3.02	0.05	-1.46
Net Cash Used In Financing Activities	0.00	0.00	-9.55	1.65	1.11
Net Inc./Dec In Cash And Cash Equivalents	14.41	6.04	-4.96	13.78	7.35
Cash And Cash Equivalents At End Of The Year	36.65	22.24	16.21	21.16	7.38

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

73.37%

FII Shareholding

0.09%

DII Shareholding

0.00%

Public Shareholding

26.54%

**Promoter pledged shareholding 73.37%

About Par Drugs & Chemicals Ltd

Par Drugs & Chemicals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 249.87 crores. It has reported a sales of Rs. 34.66 crores and a net profit of Rs. 8.6 crores for the quarter ended December 2018. The company management includes FALGUN VALLABHBHAI SAVANI, FALGUN VALLABHBHAI SAVANI,JIGNESHBHAI VALLABHBHAI SAVANI,GHANSHAYAMBHAI BHAGVANBHAI SAVANI,Nayna Jignesh Savani,Krishna Mitulbhai Shah,Kajal Chintanbhai Vaghani,Pravin Manjibhai Bhayani,Bintal Bhaveshkumar Shah (Par Drugs & Chemicals Ltd) among others.

Chairman

FALGUN VALLABHBHAI SAVANI

Registered office

805 Dwarkesh Complex,RC Dutt Road Alkapuri,Vadodara,Gujarat,390007

FAX :

Background

Incorporation Year1999

Face Value₹10

Market Lot1